End of year COVID-19 vaccine manufacturing update and challenges for 2022
14:00 – 15:30
The Biotechnology Innovation Organization (BIO), the Developing Countries Vaccine Manufacturers Network (DCVMN) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) are all COVID-19 vaccine manufacturers partners of COVAX. The press briefing, hosted by IFPMA, will take stock of the progress achieved in developing and scaling up COVID-19 vaccines production, and address the challenges that need to be tackled to achieve equitable access to COVID-19 vaccines.
- Thomas Cueni, Director General, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
- Dr Michelle McMurry-Heath, President & CEO, Biotechnology Innovation Organization (BIO)
- Sai Prasad, Executive Director, Quality Operations, Bharat Biotech, and President, Developing Countries Vaccine Manufacturers Network (DCVMN)
With the introduction of data by Rasmus Bech Hansen, CEO & Founder, Airfinity.
Click here to see the full press release
Watch again on YouTube: https://youtu.be/rnImrulpFoM